Back

Validation of digital cardiovascular risk score (DiCAVA) in the United States All of Us dataset

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk score for risk prediction in cardiovascular disease Scores ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Zhiqi Yao

CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)

7 More presentations in this session

Presentation thumbnail
The incremetal predictive value of pulse wave velocity over score2 in the setting of primary cardiovascular prevention: a 6-year follow-up study
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model
Doctor S. Rao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis on the predictive value of the C2HEST score to predict new onset atrial fibrillation in >11 million Western and Asian subjects.
Associate Professor D. Pastori (Rome, IT)
Abstract Slides Video
Presentation thumbnail
The MADIT-ICD benefit risk score for Japanese patients -from Nippon Storm study-
Doctor Y. Takanashi (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Enhancing primary prevention: the incremental predictive value of NTproBNP beyond ASCVD risk assessment
Doctor J. Simoes De Azevedo Massa Pereira (Faro, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk score for risk prediction in cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Performance of the PREVENT risk score for atherosclerotic cardiovascular disease in a diverse population-based cohort study: comparative assessment against the recalibrated WHO CVD risk score
thumbnail
Congress Presentation
Redefining cardiovascular risk evaluation: employing the CaRi-Heart validated FAI-score in patients screened with SCORE2 and CAD-RADS 2.0 techniques
thumbnail
Congress Presentation
Prediction of cardiovascular risk in patients type 2 diabetes using the SCORE2-Diabetes risk score

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources